-
Forward Look
The Cost of PrescriptionsFinancial factors can influence cancer patients' use of medications
by Kate Yandell
-
Q&A
Trial GuideResearcher Tom Marsilje is helping fellow colorectal cancer patients sort through clinical trials.
by Kate Yandell
-
Sound Advice
Summer 2017vol 07 | issue 02
Assisting a co-worker with cancer, what you should ask your doctor, and dating and cancer. -
Your Cancer Guide
Talking With Your Young ChildrenFollow these tips for discussing your diagnosis and treatment plan with your kids.
by Hester Hill Schnipper
-
The Affordable Care Act and Cancer PatientsCancer survivors tell their stories and researchers take a broad view.
by Kevin McLaughlin
-
Sound Advice
Your Questions, Our Answers – Spring 2017The sugar-feeds-cancer myth, talking to a friend with cancer, and facing down "scanxiety."
-
Your Cancer Guide
How Much Do You Want to Share?Determining what to tell people about your cancer requires careful thought.
by Hester Hill Schnipper
-
Caregiving With Confidence
In for the Long HaulWhen cancer becomes a chronic condition, caregiving requires adjusting to a new normal.
by Aimee Swartz
-
Survivor Profile
Putting Her Armor OnAn acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.
by Jennifer Walker
-
Healthy Habits
Movement for HealthA community program helps cancer patients and survivors experience the benefits of physical activity.
by Kate Yandell
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
